MedTrace Logo

Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"

NCT00222404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 556

Last updated 2010-11-05

No results posted yet for this study

Summary

The purpose of this study is to correlate molecular genetic profile with response to chemotherapy in case of primary chemotherapy treatment for non-small cells lung carcinoma.

Conditions

  • Carcinoma, Non-Small-Cell Lung

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Chritian Brambilla, Pr. · INSERM U578

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2010-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00222404 on ClinicalTrials.gov